Microdosing won’t be the right choice for everyone. But for many patients, it’s already proving to be the difference between quitting obesity treatment early and making lasting progress.
The post What if Less Can Be More? A New Approach to GLP-1 Weight Loss Medications appeared first on MedCity News.
